{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:31:43Z","timestamp":1788427903530,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"19","license":[{"start":{"date-parts":[[2014,4,26]],"date-time":"2014-04-26T00:00:00Z","timestamp":1398470400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s00213-014-3520-7","type":"journal-article","created":{"date-parts":[[2014,4,25]],"date-time":"2014-04-25T09:16:44Z","timestamp":1398417404000},"page":"3817-3828","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Neuroendocrine and sympathetic responses to an orexin receptor antagonist, SB-649868, and Alprazolam following insulin-induced hypoglycemia in humans"],"prefix":"10.1007","volume":"231","author":[{"given":"Ameera X.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam R.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep J.","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ponmani","family":"Kanakaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Napolitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelize","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward T.","family":"Bullmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,26]]},"reference":[{"key":"3520_CR1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature06310","volume":"450","author":"AR Adamantidis","year":"2007","unstructured":"Adamantidis AR, Zhang F, Aravanis AM, Deisseroth K, de Lecea L (2007) Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature 450:420\u2013424","journal-title":"Nature"},{"key":"3520_CR2","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1152\/ajplegacy.1964.207.5.1146","volume":"207","author":"B Anand","year":"1964","unstructured":"Anand B, Chhina G, Sharma K, Dua S, Singh B (1964) Activity of single neurons in the hypothalamic feeding centers: effect of glucose. Am J Physiol 207:1146\u20131154","journal-title":"Am J Physiol"},{"key":"3520_CR3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/0269881106063889","volume":"21","author":"JE Bailey","year":"2007","unstructured":"Bailey JE, Kendrick A, Diaper A, Potokar JP, Nutt DJ (2007) A validation of the 7.5\u00a0% CO2 model of GAD using paroxetine and lorazepam in healthy volunteers. J Psychopharmacol 21:42\u201349","journal-title":"J Psychopharmacol"},{"key":"3520_CR4","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/npp.2011.310","volume":"37","author":"P Bettica","year":"2012","unstructured":"Bettica P, Squassante L, Groeger JA, Gennery B, Winsky-Sommerer R, Dijk D (2012a) Differential effects of a dual orexin receptor antagonist (SB-649868) and zolpidem on sleep initiation and consolidation, SWS, REM sleep, and EEG power spectra in a model of situational insomnia. Neuropsychopharmacology 37:1224\u20131233","journal-title":"Neuropsychopharmacology"},{"key":"3520_CR5","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1177\/0269881111408954","volume":"26","author":"P Bettica","year":"2012","unstructured":"Bettica P, Nucci G, Pyke C, Squassante L, Zamuner S, Ratti E, Gomeni R, Alexander R (2012b) Phase I studies on the safety, tolerability, pharmacokinetics and pharmacodynamics of SB-649868, a novel dual orexin receptor antagonist. J Psychopharmacol 26:1058\u20131070","journal-title":"J Psychopharmacol"},{"key":"3520_CR6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00418-003-0562-z","volume":"120","author":"M Blanco","year":"2003","unstructured":"Blanco M, Gallego R, Garcia-Caballero T, Di\u00e9guez C, Beiras A (2003) Cellular localization of orexins in human anterior pituitary. Histochem Cell Biol 120:259\u2013264","journal-title":"Histochem Cell Biol"},{"key":"3520_CR7","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1523\/JNEUROSCI.4925-04.2005","volume":"25","author":"D Burdakov","year":"2005","unstructured":"Burdakov D, Gerasimenko O, Verkhratsky A (2005) Physiological changes in glucose differentially modulate the excitability of hypothalamic melanin-concentrating hormone and orexin neurons in situ. J Neurosci 25:2429\u20132433","journal-title":"J Neurosci"},{"key":"3520_CR8","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.2337\/diabetes.48.11.2132","volume":"48","author":"XJ Cai","year":"1999","unstructured":"Cai XJ, Widdowson PS, Harrold J, Wilson S, Buckingham RE, Arch JRS, Tadayyon M, Clapham JC, Wilding J, Wi G (1999) Hypothalamic orexin expression: modulation by blood glucose and feeding. Diabetes 48:2132\u20132137","journal-title":"Diabetes"},{"key":"3520_CR9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2337\/diabetes.50.1.105","volume":"50","author":"XJ Cai","year":"2001","unstructured":"Cai XJ, Evans ML, Lister CA, Leslie RA, Arch JRS, Wilson S, Williams G (2001) Hypoglycemia activates orexin neurons and by the nucleus of the solitary tract. Diabetes 50:105\u2013112","journal-title":"Diabetes"},{"key":"3520_CR10","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1172\/JCI114626","volume":"85","author":"A Caraty","year":"1990","unstructured":"Caraty A, Grino M, Locatelli A, Guillaume V, Boudouresque F, Conte-Devolx B (1990) Insulin-induced hypoglycaemia stimulates corticotropin-releasing factor and arginine vasopressin secretion into hypophysial portal blood of conscious, unrestrained rams. J Clin Investig 85:1716\u20131721","journal-title":"J Clin Investig"},{"key":"3520_CR11","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.neures.2006.11.009","volume":"57","author":"H Chang","year":"2007","unstructured":"Chang H, Saito T, Ohiwa N, Tateoka M, Deocaris CC, Fujikawa T, Soya H (2007) Inhibitory effects of an orexin-2 receptor antagonist on orexin A and stress-induced ACTH responses in conscious rats. Neurosci Res 57:462\u2013466","journal-title":"Neurosci Res"},{"key":"3520_CR12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0092-8674(00)81973-X","volume":"98","author":"RM Chemelli","year":"1999","unstructured":"Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, Yanagisawa M (1999) Narcolepsy in orexin knockout mice : molecular genetics of sleep regulation at Dallas. Cell 98:437\u2013451","journal-title":"Cell"},{"key":"3520_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2012.07.007","volume":"692","author":"S Faedo","year":"2012","unstructured":"Faedo S, Perdon\u00e0 E, Antolini M, di Fabio R, Merlo Pich E, Corsi M (2012) Functional and binding kinetic studies make a distinction between OX(1) and OX(2) orexin receptor antagonists. Eur J Pharmacol 692:1\u20139","journal-title":"Eur J Pharmacol"},{"key":"3520_CR14","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/0026-0495(86)90245-3","volume":"35","author":"HR Fish","year":"1986","unstructured":"Fish HR, Chernow B, O\u2019Brian JT (1986) Endocrine and neurophysiologic responses of the pituitary to insulin-induced hypoglycemia: a review. Metabolism 35:763\u2013780","journal-title":"Metabolism"},{"key":"3520_CR15","first-page":"951","volume":"64","author":"J Gaab","year":"2002","unstructured":"Gaab J (2002) Hypothalamic-pituitary-adrenal axis reactivity in chronic fatigue syndrome and health under psychological, physiological, and pharmacological stimulation. Psychosom Med 64:951\u2013962","journal-title":"Psychosom Med"},{"key":"3520_CR16","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1365-2265.2003.01847.x","volume":"59","author":"R Giordano","year":"2003","unstructured":"Giordano R, Grottoli S, Brossa P, Pellegrino M, Destefanis S, Lanfranco F, Gianotti L, Ghigo E, Arvat E (2003) Alprazolam (a benzodiazepine activating GABA receptor) reduces the neuroendocrine responses to insulin-induced hypoglycaemia in humans. Clin Endocrinol 59:314\u2013320","journal-title":"Clin Endocrinol"},{"key":"3520_CR17","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S0006-3223(97)00160-1","volume":"42","author":"JM Gorman","year":"1997","unstructured":"Gorman JM, Browne ST, La P, Martinez J, Welkowitz L, Coplan JD, Goetz RR, Kent J, Klein DF (1997) Effect of antipanic treatment on response to carbon dioxide. Biol Psychiatry 42:982\u2013991","journal-title":"Biol Psychiatry"},{"key":"3520_CR18","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1172\/JCI105357","volume":"45","author":"FC Greenwood","year":"1966","unstructured":"Greenwood FC, Landon J, Stamp TC (1966) The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin in control subjects. J Clin Investig 45:429\u2013436","journal-title":"J Clin Investig"},{"key":"3520_CR19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0304-3940(98)00976-8","volume":"262","author":"B Griffond","year":"1999","unstructured":"Griffond B, Risold PY, Jacquemard C, Colard C, Fellmann D (1999) Insulin-induced hypoglycemia increases preprohypocretin (orexin) mRNA in the rat lateral hypothalamic area. Neurosci Lett 262:77\u201380","journal-title":"Neurosci Lett"},{"key":"3520_CR20","doi-asserted-by":"crossref","first-page":"10911","DOI":"10.1073\/pnas.96.19.10911","volume":"96","author":"JJ Hagan","year":"1999","unstructured":"Hagan JJ, Leslie RA, Patel S, Evans ML, Wattam TA, Holmes S, Benham CD, Taylor SG, Routledge C, Hemmati P, Munton RP, Ashmeade TE, Shah AS, Hatcher JP, Hatcher PD, Jones DN, Smith MI, Piper DC, Hunter AJ, Porter RA et al (1999) Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci U S A 96:10911\u201310916","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3520_CR21","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1006\/bbrc.2000.2412","volume":"270","author":"T Ida","year":"2000","unstructured":"Ida T, Nakahara K, Murakami T, Hanada R, Nakazato M, Murakami N (2000a) Possible involvement of orexin in the stress reaction in rats. Biochem Biophys Res Commun 270:318\u2013323","journal-title":"Biochem Biophys Res Commun"},{"key":"3520_CR22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0304-3940(00)01498-1","volume":"293","author":"T Ida","year":"2000","unstructured":"Ida T, Nakahara K, Kuroiwa T, Fukui K, Nakazato M, Murakami T, Murakami N (2000b) Both corticotropin releasing factor and neuropeptide Y are involved in the effect of orexin (hypocretin) on the food intake in rats. Neurosci Lett 293:119\u2013122","journal-title":"Neurosci Lett"},{"key":"3520_CR23","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1046\/j.1365-2826.2000.00572.x","volume":"12","author":"M J\u00e1szber\u00e9nyi","year":"2000","unstructured":"J\u00e1szber\u00e9nyi M, Bujdos\u00f3 E, Pataki I, Telegdy G (2000) Effects of orexins on the hypothalamic-pituitary-adrenal system. J Neuroendocrinol 12:1174\u20131178","journal-title":"J Neuroendocrinol"},{"key":"3520_CR24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nm.2075","volume":"16","author":"PL Johnson","year":"2010","unstructured":"Johnson PL, Truitt W, Fitz SD, Minick PE, Dietrich A, Sanghani S, Tr\u00a8askman-Bendz L, Goddard AW, Brundin L, Shekhar A (2010) A key role for orexin in panic anxiety. Nat Med 16:111\u2013115","journal-title":"Nat Med"},{"key":"3520_CR25","doi-asserted-by":"crossref","unstructured":"Johnson PL, Samuels BC, Fitz SD, Lightman SL, Lowry CA, Shekhar A (2012a) Activation of the orexin 1 receptor is a critical component of CO2-mediated anxiety and hypertension but not bradycardia. Neuropsychopharm 37:1911\u20131922","DOI":"10.1038\/npp.2012.38"},{"key":"3520_CR26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/B978-0-444-59489-1.00009-4","volume":"198","author":"PL Johnson","year":"2012","unstructured":"Johnson PL, Molosh A, Fitz SD, Truitt WA, Shekhar A (2012b) Orexin, stress, and anxiety\/panic states. Prog Brain Res 198:133\u2013161","journal-title":"Prog Brain Res"},{"key":"3520_CR27","first-page":"1977","volume":"11","author":"M Kuru","year":"2000","unstructured":"Kuru M, Ueta Y, Serino R, Nakazato M, Yamamoto Y, Shibuya I, Yamashita H (2000) Centrally administered orexin\/hypocretin activates HPA axis in rats. Neuroendocrinology 11:1977\u20131980","journal-title":"Neuroendocrinology"},{"key":"3520_CR28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00213-010-1948-y","volume":"212","author":"Y Li","year":"2010","unstructured":"Li Y, Li S, Wei C, Wang H, Sui N, Kirouac G (2010) Orexins in the paraventricular nucleus of the thalamus mediate anxiety-like responses in rats. Psychopharmacology 212:251\u2013265","journal-title":"Psychopharmacology"},{"key":"3520_CR29","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)81965-0","volume":"98","author":"L Lin","year":"1999","unstructured":"Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, Qiu X, de Jong PJ, Nishino S, Mignot E (1999) The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98:365\u2013376","journal-title":"Cell"},{"key":"3520_CR30","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.2337\/diabetes.50.11.2431","volume":"50","author":"XH Liu","year":"2001","unstructured":"Liu XH, Morris R, Spiller D, White M, Williams G (2001) Orexin a preferentially excites glucose-sensitive neurons in the lateral hypothalamus of the rat in vitro. Diabetes 50:2431\u20132437","journal-title":"Diabetes"},{"key":"3520_CR31","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.1210\/endo.140.12.7287","volume":"140","author":"M Lopez","year":"1999","unstructured":"Lopez M, Senaris R, Gallego R, Garcia-Caballero T, Lago F, Seoane L, Casanueva F, Dieguez C (1999) Orexin receptors are expressed in the adrenal medulla of the rat. Endocrinology 140:5991\u20135994","journal-title":"Endocrinology"},{"key":"3520_CR32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.regpep.2003.10.003","volume":"117","author":"PJ Martins","year":"2004","unstructured":"Martins PJ, D\u2019Almeida V, Pedrazzoli M, Lin L, Mignot E, Tufik S (2004) Increased hypocretin-1 (orexin-a) levels in cerebrospinal fluid of rats after short-term forced activity. Regul Pept 117:155\u2013158","journal-title":"Regul Pept"},{"key":"3520_CR33","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.1523\/JNEUROSCI.6506-10.2011","volume":"31","author":"M Mieda","year":"2011","unstructured":"Mieda M, Hasegawa E, Kisanuki YY, Sinton CM, Yanagisawa M, Sakurai T (2011) Differential roles of orexin receptor-1 and -2 in the regulation of non-REM and REM sleep. J Neurosci 31:6518\u20136526","journal-title":"J Neurosci"},{"key":"3520_CR34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0304-3940(99)00177-9","volume":"264","author":"T Moriguchi","year":"1999","unstructured":"Moriguchi T, Sakurai T, Nambu T, Yanagisawa M, Goto K (1999) Neurons containing orexin in the lateral hypothalamic area of the adult rat brain are activated by insulin-induced acute hypoglycemia. Neurosci Lett 264:101\u2013104","journal-title":"Neurosci Lett"},{"key":"3520_CR35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0167-0115(01)00356-1","volume":"104","author":"T Nanmoku","year":"2002","unstructured":"Nanmoku T, Isobe K, Sakurai T, Yamanaka A, Takekoshi K, Kawakami Y, Goto K, Nakai T (2002) Effects of orexin on cultured porcine adrenal medullary and cortex cells. Regul Pept 104:125\u2013130","journal-title":"Regul Pept"},{"key":"3520_CR36","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/222282a0","volume":"222","author":"Y Oomura","year":"1969","unstructured":"Oomura Y, Ono T, Ooyama H, Wayner M (1969) Glucose and osmosensitive neurones of the rat hypothalamus. Nature 222:282\u2013284","journal-title":"Nature"},{"key":"3520_CR37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2337\/diabetes.52.1.111","volume":"52","author":"R Ouedraogo","year":"2003","unstructured":"Ouedraogo R, N\u00a8aslund E, Kirchgessner AL (2003) Glucose regulates the release of orexin-A from the endocrine pancreas. Diabetes 52:111\u2013117","journal-title":"Diabetes"},{"key":"3520_CR38","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1210\/endo-117-1-323","volume":"117","author":"P Plotsky","year":"1985","unstructured":"Plotsky P, Bruhn T, Vale W (1985) Hypophysiotropic regulation of adrenocorticotropin secretion in response to insulin-induced hypoglycaemia. Endocrinology 117:323\u2013329","journal-title":"Endocrinology"},{"key":"3520_CR39","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1177\/0269881105056533","volume":"19","author":"SZ Poma","year":"2005","unstructured":"Poma SZ, Milleri S, Squassante L, Nucci G, Bani M, Perini GI, Merlo-Pich E (2005) Characterization of a 7\u00a0% carbon dioxide (CO2) inhalation paradigm to evoke anxiety symptoms in healthy subjects. J Psychopharmacol 19:494\u2013503","journal-title":"J Psychopharmacol"},{"key":"3520_CR40","doi-asserted-by":"crossref","first-page":"5607","DOI":"10.1523\/JNEUROSCI.23-13-05607.2003","volume":"23","author":"TM Reyes","year":"2003","unstructured":"Reyes TM, Walker JR, DeCino C, Hogenesch JB, Sawchenko PE (2003) Categorically distinct acute stressors elicit dissimilar transcriptional profiles in the paraventricular nucleus of the hypothalamus. J Neurosci 23:5607\u20135616","journal-title":"J Neurosci"},{"key":"3520_CR41","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.regpep.2003.12.014","volume":"118","author":"F Sakamoto","year":"2004","unstructured":"Sakamoto F, Yamada S, Ueta Y (2004) Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons. Regul Pept 118:183\u2013191","journal-title":"Regul Pept"},{"key":"3520_CR42","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrn2092","volume":"8","author":"T Sakurai","year":"2007","unstructured":"Sakurai T (2007) The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci 8:171\u2013181","journal-title":"Nat Rev Neurosci"},{"key":"3520_CR43","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","volume":"92","author":"T Sakurai","year":"1998","unstructured":"Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson J, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ et al (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92:573\u2013585","journal-title":"Cell"},{"key":"3520_CR44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0167-0115(01)00353-6","volume":"104","author":"WK Samson","year":"2002","unstructured":"Samson WK, Taylor MM, Follwell M, Ferguson AV (2002) Orexin actions in hypothalamic paraventricular nucleus: physiological consequences and cellular correlates. Regul Pept 104:97\u2013103","journal-title":"Regul Pept"},{"key":"3520_CR45","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/1097-4547(20001015)62:2<161::AID-JNR1>3.0.CO;2-1","volume":"62","author":"JG Sutcliffe","year":"2000","unstructured":"Sutcliffe JG, de Lecea L (2000) The hypocretins: excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding. J Neurosci Res 62:161\u2013168","journal-title":"J Neurosci Res"},{"key":"3520_CR46","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.pnpbp.2003.10.005","volume":"28","author":"MA Duinen van","year":"2004","unstructured":"van Duinen MA, Schruers KRJ, Jaegers E, Maes M, Griez EJL (2004) Hypothalamic-pituitary-adrenal axis function following a 35% CO2 inhalation in healthy volunteers. Prog Neuro-Psychopharmacol 28:279\u2013283","journal-title":"Prog Neuro-Psychopharmacol"},{"key":"3520_CR47","doi-asserted-by":"crossref","first-page":"10685","DOI":"10.1073\/pnas.0702676104","volume":"104","author":"RH Williams","year":"2007","unstructured":"Williams RH, Jensen LT, Verkhratsky A, Fugger L, Burdakov D (2007) Control of hypothalamic orexin neurons by acid and CO2. Proc Natl Acad Sci U S A 104:10685\u201310690","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3520_CR48","doi-asserted-by":"crossref","first-page":"11439","DOI":"10.1523\/JNEUROSCI.3459-04.2004","volume":"24","author":"R Winsky-Sommerer","year":"2004","unstructured":"Winsky-Sommerer R, Yamanaka A, Diano S, Borok E, Roberts AJ, Sakurai T, Kilduff TS, Horvath TL, de Lecea L (2004) Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J Neurosci 24:11439\u201311448","journal-title":"J Neurosci"},{"key":"3520_CR49","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0896-6273(03)00331-3","volume":"38","author":"A Yamanaka","year":"2003","unstructured":"Yamanaka A, Beuckmann CT, Willie JT, Hara J, Tsujino N, Mieda M, Tominaga M, Yagami KI, Sugiyama F, Goto K, Yanagisawa M, Sakurai T (2003) Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 38:701\u2013713","journal-title":"Neuron"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-014-3520-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-014-3520-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-014-3520-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T21:59:57Z","timestamp":1565387997000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-014-3520-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,26]]},"references-count":49,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["3520"],"URL":"https:\/\/doi.org\/10.1007\/s00213-014-3520-7","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,26]]}}}